Chinese Molecular Diagnostics Firm GenomePrecision Raises Series B Round

Beijing GenomePrecision Technology Co., a Chinese precision medicine firm focused on molecular diagnostics, has raised a nearly RMB100 million (US$14.75 million) series B financing round from a group of investors, according to a statement released on the WeChat official account of one investor on Monday.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

LEAVE A REPLY